Insights from the TESLA registry, an investigator-initiated real-world study of robotically-assisted percutaneous coronary intervention (PCI) at centres in Europe and Japan, demonstrate a high rate of clinical success for robotic techniques in the cath lab among more than 500 patients.
Dariusz Dudek (Jagiellonian University, Krakow, Poland) spoke to Cardiovascular News about the results of the study and its implications for the spread of robotic technologies in the cath lab, shortly after presenting the findings at EuroPCR 2024 (14–17 May; Paris, France).
The robotic platform used in the TESLA registry is the second generation CorPath GRX (Siemens Healthineers) which allows remote control of a balloon or stent, wire or guiding catheter through joysticks and a touch screen console. The primary benefit of this technology is that there is no need for radiation exposure to the interventional team, which also eliminates the need to wear protective lead clothing that has been linked to orthopaedic injury, Dudek explains.
“It is clear that we have a very high clinical success rate – at the level of 95%,” Dudek says, underscoring the point that 74% of all cases were done completely with the robotic arm.
